BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Urgent Field Safety Notice for BOND Ready-to-Use Primary Antibody CDX2 (EP25) by Leica Biosystems Newcastle Ltd

Product group In-vitro diagnostics - haematological, histological and cytological products
Reference 16266/21

For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.

Urgent Field Safety Notice for BOND Ready-to-Use Primary Antibody CDX2 (EP25) by Leica Biosystems Newcastle Ltd , Download_VeroeffentlichtAm_EN PDF, 122KB, File does not meet accessibility standards